D-1813-2015 Class III Terminated

Recalled by EMD Serono, Inc. — Rockland, MA

FDA drug recall D-1813-2015 was initiated by EMD Serono, Inc. on Sep 10, 2015 and is designated Class III. Reason for recall: Chemical Contamination: impurity failure due to chemical contamination of the active ingredient. The recall status is terminated (terminated Feb 13, 2017). Affected quantity: 37,078 cartons.

Recall details

Product Type
Drugs
Report Date
Sep 23, 2015
Initiation Date
Sep 10, 2015
Termination Date
Feb 13, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37,078 cartons

Product description

ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.

Reason for recall

Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.

Distribution pattern

Nationwide

Code information

Lot #: 233169, Exp 02/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1813-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1813-2015. Report a data issue: hello@regdatalab.com.